Effect of levosimendan on SDNN and SDANN changes in patients with acute decompensated heart failure and its clinical efficacy and safety
10.3969/j.issn.1005-1678.2017.05.081
- VernacularTitle:左西孟旦对急性失代偿性心力衰竭全部窦性心搏RR间期的标准差、RR间期平均值标准差值的影响及其临床治疗效果分析
- Author:
Mingying LI
;
Yun DING
;
Yanfei WU
;
Liang XIA
- Keywords:
levosimendan;
heart failure;
heart rate variability;
cardiac function
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):246-248
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic effect of levosimendan on acute decompensated heart failure and its effect on SDNN and SDANN values.MethodsThe clinical data of patients with acute decompensated heart failure treated in Zhejiang Greentown Cardiovascular Hospital from January 2014 to August 2016 were retrospectively analyzed.According to their treatment methods, they were divided into control group and observation group.There were 49 cases in the control group and 71 cases in the observation group.The control group was given conventional drug treatment, the observation group was given levosimendan treatment on the basis of the control group.The therapeutic effects of the two groups were observed.The difference of cardiac function, SDNN, SDANN value and adverse reaction between the two groups were compared before and after treatment.ResultsAfter treatment, the observation group efficiency was 98.59%, significantly higher than the control group;the observation group LAD, RAD, LVESD, LVEDD and BNP lower than the control group, the level of LVEF was higher than the control group, the difference was statistically significant (P<0.05);the observation group SDNN, SDANN, RMSSD and PNN50 (%) was higher than that of the control group, the difference was statistically significant (P<0.05).ConclusionLevosimendan has good therapeutic effect on acute decompensated heart failure, can significantly improve the level of SDNN, SDANN, and the incidence of adverse reactions is low.
